Fink JK, Brouwers P, Barton N, Malekzadeh MH, Sato S, Hill S, Cohen WE, Fivush B, Gahl WA (1989) Neurologic complications in long-standing nephropathic cystinosis
Combination with Basal Insulin In a 30-week, double-blind trial (NCT02305381), 397 patients with type 2 diabetes mellitus inadequately controlled with basal insulin, with or without metformin, were randomized to semaglutide 0.5 mg once weekly, semaglutide 1 mg once weekly, or placebo
"It's a legal risk to compounding pharmacies" that could face lawsuits from massive companies: Novo Nordisk and Eli Lily
Many people use it without apparent issues
Verywell Health